The Efficacy and Tolerability of Acarbose in Healthy Individuals

Completed · Phase 4

Conditions studied: Tolerance, Side Effect, Glucose Response

In brief

A Prospective Trial for Acarbose in Healthy Individuals Assessing Safety and Efficacy in Reducing Glucose Spikes After Carbohydrate Consumption.

Key facts

Study ID

NCT05542849

Run by

AgelessRx

People needed

15

Starts

2022-08-10

Expected to finish

2022-10-05

Last updated by the study team

2023-07-27

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18-85
• Any sex
• Any ethnicity
• Interest in taking Acarbose off-label
• Approved by the AgelessRx Medical team to take Acarbose
• Willing and technically able to use and operate a CGM
• Own a CGM-compatible phone
• Relatively good health with only well-managed chronic diseases (hypertension, coronary artery disease, type II diabetes, etc.) clinically stable
• Adequate cognitive function to be able to give informed consent

You may not qualify if…

• Diabetes of any type
• Taking metformin or any other glucose lowering medication
• Any uncontrolled endocrine disorder (thyroid, pancreatic, adrenal, etc...)
• Active malignancy of any kind
• Clinically relevant renal or kidney disease or dysfunction
• History of eating disorder
• Taking any medication, or has any medical condition that might interfere with the action of acarbose of the CGM sensor

Where it is running

• AgelessRx — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.